| | | |

In Search of a Diagnostic Blood Test for Mesothelioma

ByAlex Strauss

2105823_blood test5Doctors in Turkey believe they may be a step closer to developing a more sensitive blood test that could improve the odds of surviving mesothelioma by allowing it to be identified earlier.

While it’s extremely rare and usually only diagnosed in people who have been exposed to asbestos, malignant pleural mesothelioma is also one of the most universally lethal cancers.

One reason for the high death rate among mesothelioma patients is that the disease often causes no symptoms until it is in its advanced stages, when treatments like chemotherapy and radiation are less likely to work.

But a team of doctors in Diyarbakir, Turkey claim to have identified two of the most important biomarkers in blood serum that could be red flags for early mesothelioma diagnosis.

Biomarkers for Mesothelioma

Scientists from around the world have long been searching for the perfect biomarker or biomarkers that could indicate that a person definitely has malignant mesothelioma.

So far, no single biomarker has been found to be definitive for mesothelioma diagnosis, though several have been shown to be elevated in people with mesothelioma.

The Turkish researchers used these previously-tested biomarkers as their starting point. Their study included serum level tests for soluble mesothelin-related peptide (SMRP), thioredoxin-1 (TRX), epidermal growth factor receptor (EGFR), fibulin-3, syndecan-1 (SDC-1) and mesothelin.

Testing Mesothelioma Biomarkers

To determine which biomarkers were most valuable for diagnosing mesothelioma as early as possible, the team divided study participants into three groups: healthy individuals, people who had been exposed to asbestos but were not known to have mesothelioma, and mesothelioma patients.

Each participant was tested to determine their level of each of the six biomarkers. When the results were evaluated, there were two clear mesothelioma biomarker winners.

“SMRP and TRX increased in a graded fashion from the controls to asbestos exposure and malignant pleural mesothelioma groups,” writes lead author Melike Demir, a member of the Dicle University Faculty of Medicine in Diyarbakir. “These two seem to be the most valuable biomarkers for the diagnosis of malignant pleural mesothelioma, both individually and in combination.”

What Does This Mean for Mesothelioma Diagnosis?

The MESOMARK assay, the most well-known blood test for mesothelioma, is already being used to test suspected mesothelioma patients for levels of SMRP (though not TRW), but the test has to be used in conjunction with other diagnostic tools like imaging studies and tissue biopsies.

Other scientists elsewhere in the world are also continuing to look for and test potential mesothelioma biomarkers.

Until a definitive mesothelioma blood test is available, people who have been exposed to asbestos should be aware of the symptoms of mesothelioma and should visit their doctors regularly. As with most cancers, mesothelioma is most responsive to treatment in its earliest stages.

Source:

Demir, M, et al, “Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure”, March 31, 2016, Lung, Epub ahead of print, http://link.springer.com/article/10.1007/s00408-016-9868-1

 

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    ByAlex Strauss

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…